StockViz
RANKINGS
Atai Life Sciences N.V.
NasdaqGM:ATAI
Sector
Location
Market Cap
USD 748.87 M
Share Price
USD 3.53
Avg Daily Volume
3,296,596
Change (1 day)
9.29%
Change (1 year)
138.51%
Change (YTD)
165.41%
Atai Life Sciences N.V. Key Metrics 2020 - 2025
This table shows the Key Metrics for Atai Life Sciences N.V. going from 2020 until 2025. Key metrics are specific quantitative measures used to assess the performance and progress of a company, often tailored to its industry and objectives, providing insights into growth, profitability, and operational efficiency.
Key Metrics
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
AbbVie Inc.
USD 184.85
ABBV
-4.41
-2.33%
Novo Nordisk A/S
USD 64.18
NOVO-B.CO
-0.20
-0.32%
Roche Holding AG
USD 338.18
RO.SW
-2.81
-0.82%
Novartis AG
USD 114.67
NOVN.SW
-0.44
-0.38%
Abbott Laboratories
USD 124.42
ABT
+0.75
0.61%
AstraZeneca PLC
USD 138.01
AZN.L
-0.01
-0.01%
Merck & Co., Inc.
USD 79.31
MRK
-0.65
-0.81%
Amgen Inc.
USD 295.87
AMGN
+1.11
0.38%
Pfizer Inc.
USD 24.26
PFE
-0.21
-0.86%
Gilead Sciences, Inc.
USD 108.28
GILD
+0.06
0.06%
Vertex Pharmaceuticals Incorporated
USD 458.49
VRTX
-1.32
-0.29%
Sanofi
USD 96.20
SAN.PA
-0.42
-0.44%
Bristol-Myers Squibb Company
USD 46.69
BMY
-0.67
-1.42%
CSL Limited
USD 166.56
CSL.AX
-0.83
-0.50%
Chugai Pharmaceutical Co., Ltd.
USD 46.18
4519.T
-0.87
-1.84%
GSK plc
USD 18.13
GSK.L
+0.05
0.30%
Regeneron Pharmaceuticals, Inc.
USD 545.53
REGN
+3.01
0.56%
MERCK Kommanditgesellschaft auf Aktien
USD 128.35
MRK.DE
-0.23
-0.18%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.08
600276.SS
-0.10
-1.27%
Takeda Pharmaceutical Company Limited
USD 28.82
4502.T
-0.34
-1.16%